New approach for treating recurrent prostate cancer on the horizon
Monday, June 15, 2009 - 13:49
in Health & Medicine
TORONTO -- A new study shows that an alpha-particle emitting radiopeptide -- radioactive material bound to a synthetic peptide, a component of protein -- is effective for treating prostate cancer in mice, according to researchers at SNM's 56th Annual Meeting in Toronto.